Four reasons pharma is sweeping the Super Bowl despite FDA f...
The FDA has signalled increased scrutiny of D2C pharma advertising. So why is pharma stepping up its advertising at Super Bowl LX?
Amgen baulks at FDA request to withdraw Tavneos
Amgen confirmed on its fourth-quarter results call that it has resisted a request to pull Tavneos for ANCA-associated vasculitis from the US market.
How to meet your physicians where they are online
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
Expert Directed Applied Intelligence: Redefining AI in Life ...
In a new white paper from Lumanity, explore why the most powerful AI will always be human-directed.
The long-delayed promise of the microbiome, with Sam Possemi...
Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Data managers and CRAs warn of rising data quality risks due...
A new industry report uncovers the scope of a long-ignored problem in clinical trial operations.
VuuAI and Amiculum partner to transform content engagement i...
Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a GenAI-driven content production automation plat
5th mRNA-Based Therapeutics Summit Europe
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines

